Have a personal or library account? Click to login
Prevalence of Sarcopenia Among Slovenian Older Adults and Associated Risk Factors Cover

Prevalence of Sarcopenia Among Slovenian Older Adults and Associated Risk Factors

Open Access
|Feb 2025

References

  1. Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, et al. Global prevalence of sarcopenia and severe sarcopenia: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86-99. doi: 10.1002/jcsm.12783.
  2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423. doi: 10.1093/ageing/afq034.
  3. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. doi: 10.1093/ageing/afy169.
  4. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547-558. doi: 10.1093/gerona/glu010.
  5. Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. Sarcopenia definition: The position statements of the Sarcopenia Definition and Outcomes Consortium. J Am Geriatr Soc. 2020;68(7):1410-1418. doi: 10.1111/jgs.16372.
  6. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249-256. doi: 10.1016/j.jamda.2011.01.003.
  7. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300–307. doi: 10.1016/j.jamda.2019.12.012.
  8. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7(5):512-514. doi: 10.1002/jcsm.12147.
  9. Anand A, Mohta S, Agarwal S, Sharma S, Gopi S, Gunjan D, et al. European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria with population-based skeletal muscle index best predicts mortality in Asians with cirrhosis. J Clin Exp Hepatol. 2022;12(1):52-60. doi: 10.1016/j.jceh.2021.03.015.
  10. Evans WJ, Guralnik J, Cawthon P, Appleby J, Landi F, Clarke L, et al. Sarcopenia: No consensus, no diagnostic criteria, and no approved indication-How did we get here? Geroscience. 2024;46(1):183-190. doi: 10.1007/s11357-023-01016-9.
  11. Bijlsma AY, Meskers CGM, Ling CHY, Narici M, Kurrle SE, Cameron ID, et al. Defining sarcopenia: The impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Dordr). 2013;35(3):871-881. doi: 10.1007/s11357-012-9384-z.
  12. Sayer AA, Syddall H, Martin H, Patel H, Baylis D, Cooper C. The developmental origins of sarcopenia. J Nutr Health Aging. 2008;12(7):427-432. doi: 10.1007/BF02982703.
  13. Han P, Kang L, Guo Q, Wang J, Zhang W, Shen S, et al. Prevalence and Factors Associated With Sarcopenia in Suburb-dwelling Older Chinese Using the Asian Working Group for Sarcopenia Definition. J Gerontol A Biol Sci Med Sci. 2016;71(4):529–535. doi: 10.1093/gerona/glv108.
  14. Gao Q, Hu K, Yan C, Zhao B, Mei F, Chen F, et al. Associated factors of sarcopenia in community-dwelling older adults: A systematic review and meta-analysis. Nutrients. 2021;13(12):4291. doi: 10.3390/nu13124291.
  15. Liguori I, Curcio F, Russo G, Cellurale M, Aran L, Bulli G, et al. Risk of malnutrition evaluated by mini nutritional assessment and sarcopenia in noninstitutionalized elderly people. Nutr Clin Pract. 2018;33(6):879-886. doi: 10.1002/ncp.10022.
  16. Mo Y, Zhou Y, Chan H, Evans C, Maddocks M. The association between sedentary behaviour and sarcopenia in older adults: a systematic review and meta-analysis. BMC Geriatr. 2023;23(1):877. doi: 10.1186/s12877-023-04489-7.
  17. Sieber CC. Malnutrition and sarcopenia. Aging Clin Exp Res. 2019;31(6):793-798. doi: 10.1007/s40520-019-01170-1.
  18. Pišot R, Marusic U, Biolo G, Mazzucco S, Lazzer S, Grassi B, et al. Greater loss in muscle mass and function but smaller metabolic alterations in older compared with younger men following 2 wk of bed rest and recovery. J Appl Physiol (1985). 2016;120(8):922-929. doi: 10.1152/japplphysiol.00858.2015.
  19. Hämäläinen O, Tirkkonen A, Savikangas T, Alén M, Sipilä S, Hautala A. Low physical activity is a risk factor for sarcopenia: a cross-sectional analysis of two exercise trials on community-dwelling older adults. BMC Geriatr. 2024;24(1):212. doi: 10.1186/s12877-024-04764-1.
  20. Peng TC, Chen WL, Wu LW, Chang YW, Kao TW. Sarcopenia and cognitive impairment: A systematic review and meta-analysis. Clin Nutr. 2020;39(9):2695-2701. doi: 10.1016/j.clnu.2019.12.014.
  21. 21.Sui SX, Williams LJ, Holloway-Kew KL, Hyde NK, Pasco JA. Skeletal muscle health and cognitive function: A narrative review. Int J Mol Sci. 2020;22(1):255. doi: 10.3390/ijms22010255.
  22. Malmstrom TK, Morley JE. SARC-F: A simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531-532. doi: 10.1016/j.jamda.2013.05.018.
  23. Barbosa-Silva TG, Menezes AMB, Bielemann RM, Malmstrom TK, Gonzalez MC. Enhancing SARC-F: Improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc. 2016;17(12):1136-1141. doi: 10.1016/j.jamda.2016.08.004.
  24. Podsiadlo D, Richardson S. The timed “Up & Go”: A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142-148. doi: 10.1111/j.1532-5415.1991.tb01616.x.
  25. Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;15(2):116-122. doi: 10.1016/s0899-9007(98)00171-3.
  26. Armstrong T, Bull F. Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ). J Public Health (Bangkok). 2006;14(2):66-70.
  27. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271–276.
  28. Tombaugh TN. Trail Making Test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol. 2004;19(2):203-214. doi: 10.1016/S0887-6177(03)00039-8.
  29. McHugh ML. Interrater reliability: The kappa statistic. Biochem Med (Zagreb). 2012;22(3):276-282.
  30. Montemurro A, Ruiz-Cárdenas JD, Martínez-García MDM, Rodríguez-Juan JJ. Consequences of applying the different criteria of the EWGSOP2 guideline for sarcopenia case-finding in Spanish community-dwelling older adults. Arch Gerontol Geriatr. 2023;109:104964. doi: 10.1016/j.archger.2023.104964.
  31. Stuck AK, Tsai LT, Freystaetter G, Vellas B, Kanis JA, Rizzoli R, et al. Comparing prevalence of sarcopenia using twelve sarcopenia definitions in a large multinational European population of community-dwelling older adults. J Nutr Health Aging. 2023;27(3):205-212. doi: 10.1007/s12603-023-1888-y.
  32. Syddall HE, Aihie Sayer A, Dennison EM, Martin HJ, Barker DJ, Cooper C. Cohort profile: The Hertfordshire cohort study. Int J Epidemiol. 2005;34(6):1234-1242. doi: 10.1093/ije/dyi127.
  33. Westbury LD, Beaudart C, Bruyère O, Cauley JA, Cawthon P, Cruz-Jentoft AJ, et al. Recent sarcopenia definitions-prevalence, agreement and mortality associations among men: Findings from population-based cohorts. J Cachexia Sarcopenia Muscle. 2023;14(1):565-575. doi: 10.1002/jcsm.13160.
  34. Van Ancum JM, Alcazar J, Meskers CGM, Nielsen BR, Suetta C, Maier AB. Impact of using the updated EWGSOP2 definition in diagnosing sarcopenia: A clinical perspective. Arch Gerontol Geriatr. 2020;90:104125. doi: 10.1016/j.archger.2020.104125.
  35. Xu Z, Zhang P, Chen Y, Jiang J, Zhou Z, Zhu H. Comparing SARC-CalF With SARC-F for screening sarcopenia in adults with type 2 diabetes mellitus. Front Nutr. 2022;9:803924. doi: 10.3389/fnut.2022.803924.
  36. Ishimoto T, Hisamatsu K, Matsudaira N, Fujimoto T, Yano M, Hashimoto R, et al. Accuracy of determining sarcopenia using SARC-CalF in community-dwelling older adults aged 75 years and older. Clin Nutr ESPEN. 2022;52:317-321. doi: 10.1016/j.clnesp.2022.09.012.
  37. da Luz MCL, Pinho CPS, Bezerra GK de A, da Conceição Chaves de Lemos M, da Silva Diniz A, Cabral PC. SARC-F and SARC-CalF in screening for sarcopenia in older adults with Parkinson’s disease. Exp Gerontol. 2021;144:111183. doi: 10.1016/j.exger.2020.111183.
  38. Piotrowicz K, Głuszewska A, Czesak J, Fedyk-Łukasik M, Klimek E, Sánchez-Rodríguez D, et al. SARC-F as a case-finding tool for sarcopenia according to the EWGSOP2. National validation and comparison with other diagnostic standards. Aging Clin Exp Res. 2021;33(7):1821-1829. doi: 10.1007/s40520-020-01782-y.
  39. Veronese N, Smith L, Cereda E, Maggi S, Barbagallo M, Dominguez LJ, et al. Multimorbidity increases the risk for sarcopenia onset: Longitudinal analyses from the English Longitudinal Study of Ageing. Exp Gerontol. 2021;156:111624. doi: 10.1016/j.exger.2021.111624.
  40. Beaudart C, Sanchez-Rodriguez D, Locquet M, Reginster JY, Lengelé L, Bruyère O. Malnutrition as a strong predictor of the onset of sarcopenia. Nutrients. 2019;11(12):2883. doi: 10.3390/nu11122883.
  41. Chiba I, Lee S, Bae S, Makino K, Shinkai Y, Katayama O, et al. Difference in sarcopenia characteristics associated with physical activity and disability incidences in older adults. J Cachexia Sarcopenia Muscle. 2021;12(6):1983-1994. doi: 10.1002/jcsm.12801.
  42. Gomes M, Figueiredo D, Teixeira L, Poveda V, Paúl C, Santos-Silva A, et al. Physical inactivity among older adults across Europe based on the SHARE database. Age Ageing. 2017;46(1):71-77. doi: 10.1093/ageing/afw165.
  43. Benz E, Pinel A, Guillet C, Capel F, Pereira B, De Antonio M, et al. Sarcopenia and sarcopenic obesity and mortality among older people. JAMA Netw Open. 2024;7(3):e243604. doi: 10.1001/jamanetworkopen.2024.3604.
  44. Scisciola L, Fontanella RA, Surina, Cataldo V, Paolisso G, Barbieri M. Sarcopenia and cognitive function: Role of myokines in muscle brain cross-talk. Life (Basel). 2021;11(2):173. doi: 10.3390/life11020173.
  45. Yuan S, Larsson SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 2023;144:155533. doi: 10.1016/j.metabol.2023.155533.
DOI: https://doi.org/10.2478/sjph-2025-0013 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English
Page range: 103 - 111
Submitted on: Sep 18, 2024
|
Accepted on: Jan 7, 2024
|
Published on: Feb 28, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Katarina PUŠ, Saša PIŠOT, Uroš MARUŠIČ, Manca PESKAR, Kaja TERAŽ, Miloš KALC, Helena BLAŽUN VOŠNER, Peter KOKOL, Jernej ZAVRŠNIK, Boštjan ŠIMUNIČ, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.